High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen-Reference-Cited by-同舟云学术

High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen

Published:2021-04-01 Issue:2 Volume:10 Page:185-192
ISSN:2156-5333
Container-title:Journal of Adolescent and Young Adult Oncology
language:en
Short-container-title:Journal of Adolescent and Young Adult Oncology

Author:

Vijayasekharan Kalasekhar¹²³,Ramanathan Subramaniam¹²,Chinnaswamy Girish¹²,Prasad Maya¹²,Gulia Ashish¹⁴,Janu Amit¹⁵,Rekhi Bharat¹⁶,Ramadwar Mukta¹⁶,Khanna Nehal¹⁷,Laskar Siddhartha¹⁷,Puranadare Nilendu¹⁸,Bajpai Jyoti¹²,Puri Ajay¹⁴,Banavali Shripad²,Vora Tushar¹²

Affiliation:

1. Bone and Soft Tissue Disease Management Group and Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

2. Department of Pediatric Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

3. Division of Pediatric Hematology Oncology, Manipal Comprehensive Cancer Care Centre, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.

4. Department of Orthopedic Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

5. Department of Radiology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

6. Department of Pathology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

7. Department of Radiation Oncology, and Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

8. Department of Nuclear Medicine, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

Publisher

Mary Ann Liebert Inc

Subject

Oncology,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/jayao.2020.0016

Reference34 articles.

1. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

2. Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial

3. Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

4. Risk of recurrence and survival after relapse in patients with Ewing sarcoma

5. Survival After Recurrence of Ewing’s Sarcoma Family of Tumors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2022-12-17

2. Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income country;ecancermedicalscience;2022-03-01